Pivotal Bioequivalence Study of Clopacin ® , a Generic Formulation of Clopidogrel 75 mg Film-Coated Tablets

Conclusion This bioequivalence study provided robust clopidogrel pharmacokinetic data that established the bioequivalence of Clopacin® and the reference originator drug. Funding Acino Pharma AG (formerly Cimex AG)
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research